MSc T. Preijers publications

Publications MSc T. Preijers

Position: PhD Candidate
Main activities: Research
Specialisation: Clinical Pharmacology and Pharmacometrics
Focus of research: Pharmacokinetics and Pharmacodynamics of clotting factor fVIII and fIX in hemophilia.

Amsterdam UMC Research Institutes

AMC departments

All publications

de Jager Nico C. B., Bukkems Laura H., Heijdra Jessica M., Hazendonk Carolien H. C. A. M., Fijnvandraat Karin, Meijer Karina, Eikenboom Jeroen, Laros - van Gorkom Britta A. P., Leebeek Frank W. G., Cnossen Marjon H., Mathôt Ron A. A., Collins P. W., Kruip M. J. H. A., Polinder S., Lock J., van Moort I., Goedhart M. C. H. J., Coppens M., Peters M., Preijers T., Brons P., van der Meer F. J. M., Schutgens R. E. G., Fischer K., Driessens M. H. E., Zwaan C. M., van Vliet I., Liesner R., Chowdary P., Keeling D. One piece of the puzzle: Population pharmacokinetics of FVIII during perioperative Haemate P®/Humate P® treatment in von Willebrand disease patients Journal of thrombosis and haemostasis 2020;18 (2):295-305 [PubMed]

Preijers Tim, Laros-Vangorkom Britta Ap, Mathôt Ron Aa, Cnossen Marjon H. Pharmacokinetic-guided dosing of factor VIII concentrate in a morbidly obese severe haemophilia A patient undergoing orthopaedic surgery BMJ case reports 2019;12 (1) [PubMed]
Preijers Tim, Schütte Lisette M., Kruip Marieke J. H. A., Cnossen Marjon H., Leebeek Frank W. G., van Hest Reinier M., Mathôt Ron A. A. Strategies for individualized dosing of clotting factor concentrates and desmopressin in hemophilia A and B Therapeutic drug monitoring 2019;41 (2):192-212 [PubMed]

Preijers T., van Moort I., Fijnvandraat K., Leebeek F. W. G., Cnossen M. H., Mathôt R. A. A. Cross-evaluation of Pharmacokinetic-Guided Dosing Tools for Factor VIII Thrombosis and haemostasis 2018;118 (3):514-525 [PubMed]
Hazendonk H. C. A. M., Preijers T., Liesner R., Chowdary P., Hart D., Keeling D., Driessens M. H. E., Laros-van Gorkom B. A. P., van der Meer F. J. M., Meijer K., Fijnvandraat K., Leebeek F. W. G., Mathôt R. A. A., Collins P. W., Cnossen M. H. Perioperative replacement therapy in haemophilia B: An appeal to “B” more precise Haemophilia 2018;24 (4):611-618 [PubMed]
Preijers T., Hazendonk H. C. A. M., Liesner R., Chowdary P., Driessens M. H. E., Hart D., Keeling D., Laros-van Gorkom B. A. P., van der Meer F. J. M., Meijer K., Fijnvandraat K., Leebeek F. W. G., Collins P. W., Cnossen M. H., Mathôt R. A. A., Kruip M. J. A. H., Polinder S., Lock J., van Moort I., Heijdra J. M., Nederlof A., de Jager N., Coppens M., Peters M., Tamminga R. Y. J., Brons P., Eikenboom H. C. J., Schutgens R. E. G., Fischer K., Zwaan C. M., van Vliet I. Population pharmacokinetics of factor IX in hemophilia B patients undergoing surgery Journal of thrombosis and haemostasis 2018;16 (11):2196-2207 [PubMed]

Preijers T., Hazendonk H. C. A. M., Fijnvandraat K., Leebeek F. W. G., Cnossen M. H., Mathôt R. A. A. In silico evaluation of limited blood sampling strategies for individualized recombinant factor IX prophylaxis in hemophilia B patients Journal of thrombosis and haemostasis 2017;15 (9):1737-1746 [PubMed]

Lock J., de Bekker-Grob E. W., Urhan G., Peters M., Meijer K., Brons P., van der Meer F. J. M., Driessens M. H. E., Collins P. W., Fijnvandraat K., Leebeek F. W. G., Cnossen M. H., Mathôt R. A. A., Kruip M. H., de Wildt S. N., Polinder S., Ista W. G., Hazendonk H. C. A. M., van Moort I., Steyerberg E. W., Borsboom G. J. J. M., Preijers T., Stokhuijzen E., Coppens M., Middeldorp S., Tamminga R. Y. J., Laros-van Gorkom B. A. P., Eikenboom H. C. J., Schutgens R. E. G., de Meris J., Zwaan C. M., Ramnarain S., Bosschaart-Castermans R. M. M., Rotte A. E., Koolma A., Ammerlaan A. C. J. Facilitating the implementation of pharmacokinetic-guided dosing of prophylaxis in haemophilia care by discrete choice experiment Haemophilia 2016;22 (1):e1-e10 [PubMed]